Inaki Mendez-Comino

Malaga, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Dual ctDNA and CTCs analysis for minimal residual disease detection and relapse monitoring in early-stage breast cancer.

Dual ctDNA and CTCs analysis for minimal residual disease detection and relapse monitoring in early-stage breast cancer.

Journal: NPJ breast cancer

Published: February 25, 2026

The landscape of clonal hematopoiesis of indeterminate potential in long-term breast cancer survivors.

The landscape of clonal hematopoiesis of indeterminate potential in long-term breast cancer survivors.

Journal: Breast (Edinburgh, Scotland)

Published: January 07, 2026

Luminal and Basal Subtypes Across Carcinomas: Molecular Programs Beyond Tissue of Origin.

Luminal and Basal Subtypes Across Carcinomas: Molecular Programs Beyond Tissue of Origin.

Journal: Cancers

Published: July 18, 2025

Identification of minimal residual disease using the clonesight test for ultrasensitive ctDNA detection to anticipate late relapse in early breast cancer.

Identification of minimal residual disease using the clonesight test for ultrasensitive ctDNA detection to anticipate late relapse in early breast cancer.

Journal: Breast cancer research : BCR

Published: January 21, 2025

The spatially informed mFISHseq assay resolves biomarker discordance and predicts treatment response in breast cancer.

The spatially informed mFISHseq assay resolves biomarker discordance and predicts treatment response in breast cancer.

Journal: Nature communications

Published: July 01, 2024

Hodgkin lymphoma and liquid biopsy: a story to be told.

Hodgkin lymphoma and liquid biopsy: a story to be told.

Journal: Journal of experimental & clinical cancer research : CR

Published: March 12, 2024

Multiplexed RNA-FISH-guided Laser Capture Microdissection RNA Sequencing Improves Breast Cancer Molecular Subtyping, Prognostic Classification, and Predicts Response to Antibody Drug Conjugates.

Multiplexed RNA-FISH-guided Laser Capture Microdissection RNA Sequencing Improves Breast Cancer Molecular Subtyping, Prognostic Classification, and Predicts Response to Antibody Drug Conjugates.

Journal: medRxiv : the preprint server for health sciences

Published: December 18, 2023

NK cell-triggered CCL5/IFNγ-CXCL9/10 axis underlies the clinical efficacy of neoadjuvant anti-HER2 antibodies in breast cancer.

NK cell-triggered CCL5/IFNγ-CXCL9/10 axis underlies the clinical efficacy of neoadjuvant anti-HER2 antibodies in breast cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 07, 2023

Increased blood draws for ultrasensitive ctDNA and CTCs detection in early breast cancer patients.

Increased blood draws for ultrasensitive ctDNA and CTCs detection in early breast cancer patients.

Journal: NPJ breast cancer

Published: November 04, 2023

Comparative study of droplet-digital PCR and absolute Q digital PCR for ctDNA detection in early-stage breast cancer patients.

Comparative study of droplet-digital PCR and absolute Q digital PCR for ctDNA detection in early-stage breast cancer patients.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: September 20, 2023

Development of a Novel NGS Methodology for Ultrasensitive Circulating Tumor DNA Detection as a Tool for Early-Stage Breast Cancer Diagnosis.

Development of a Novel NGS Methodology for Ultrasensitive Circulating Tumor DNA Detection as a Tool for Early-Stage Breast Cancer Diagnosis.

Journal: International journal of molecular sciences

Published: November 15, 2022

Unveiling the Potential of Liquid Biopsy in HER2-Positive Breast Cancer Management.

Unveiling the Potential of Liquid Biopsy in HER2-Positive Breast Cancer Management.

Journal: Cancers

Published: December 02, 2021

Showing 1-12 of 31

Last Updated: 09/26/2026